Levonorgestrel Tablet
Product Images NDC 73581-217

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Levonorgestrel (NDC 73581-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yyba Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mymorning (My Morning After Choice)

This text provides information about a product called "MY MORNING AFTER: Zsice" which is an emergency contraceptive containing Levonorgestrel USP 1.5 mg. It is designed for women to reduce the chance of pregnancy after unprotected sex. The text includes details about usage, warnings, possible side effects, directions, and inactive ingredients. It also emphasizes that this product should not be used as regular birth control and should be taken as soon as possible within 72 hours after unprotected sex. Additionally, it offers a helpline for questions or comments.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.